Bone Biomarkers as Tools in Osteoporosis Management
- 1 December 1997
- journal article
- review article
- Published by Wolters Kluwer Health in Spine
- Vol. 22 (Supplement), 17S-24S
- https://doi.org/10.1097/00007632-199712151-00004
Abstract
Biochemical tests that can index bone turnover rate in the patient are increasingly being used in the study and management of osteoporosis. Markers of bone formation and resorption are reviewed here, including their molecular basis, relative strengths and weaknesses in clinical performance, and future potential. A bone mass measurement (e.g., by dual-energy x-ray absorptiometry) and a biochemical index of bone turnover provide different but complementary information that can aid in predicting risk of future bone loss and osteoporotic fracture. A specific and responsive bone resorption marker can also be used to monitor and establish the short-term effectiveness of an antiresorptive therapy in the patient. Bone-specific alkaline phosphatase (an osteoblast enzyme) and osteocalcin (a bone matrix protein) levels in serum are the best markers of bone formation. Collagen degradation products in urine, particularly cross-linked telopeptides and pyridinolines, have the highest specificity to bone resorption activity. The telopeptide markers (NTx and CTx) appear to be the most specific and responsive markers of systemic osteoclast activity.Keywords
This publication has 64 references indexed in Scilit:
- Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human boneBone, 1997
- Hormone Replacement Therapy in Postmenopausal Women: Urinary N-Telopeptide of Type I Collagen Monitors Therapeutic Effect and Predicts Response of Bone Mineral DensityAmerican Journal Of Medicine, 1997
- Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human OsteoclastsJournal of Biological Chemistry, 1996
- Lack of Correlation between Levels of Osteocalcin and Bone Alkaline Phosphatase in Healthy Control and Postmenopausal Osteoporotic WomenHormone and Metabolic Research, 1995
- Clinical use of biochemical markers of bone remodeling in osteoporosisBone, 1992
- Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseasesJournal of Bone and Mineral Research, 1992
- Bone Alkaline Phosphatase in Paget's DiseaseHormone and Metabolic Research, 1991
- Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnoverJournal of Bone and Mineral Research, 1990
- Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatographyAnalytical Biochemistry, 1988
- Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of boneCalcified Tissue International, 1986